Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Cox

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Surgery|January 4, 2020
Persistently increased cell-free DNA concentrations only modestly contribute to outcome and host response in sepsis survivors with chronic critical illnessRussell B Hawkins, Julie A Stortz, David C Holden, et al.
Critical Care (London, England)|May 9, 2020
Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal studyJulie A Stortz, Michael C Cox, Russell B Hawkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxelMichael C Cox, Jennifer Low, James Lee, et al.
American Journal of Surgery|August 19, 2020
Abdominal sepsis patients have a high incidence of chronic critical illness with dismal long-term outcomesMichael C Cox, Scott C Brakenridge, Julie A Stortz, et al.
JCO Precision Oncology|September 14, 2020
Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring <i>RET</i> Gene AlterationsMichael V Ortiz, Ulrike Gerdemann, Sandya Govinda Raju, et al.
Annals of Surgery|July 30, 2019
Current Epidemiology of Surgical Sepsis: Discordance Between Inpatient Mortality and 1-year OutcomesScott C Brakenridge, Philip A Efron, Michael C Cox, et al.
Journal of the American Geriatrics Society|April 16, 2020
Older Sepsis Survivors Suffer Persistent Disability Burden and Poor Long-Term SurvivalRobert T Mankowski, Stephen D Anton, Gabriela L Ghita, et al.
The Annals of Pharmacotherapy|October 2, 2003
Clinical pharmacology of flavopiridol following a 72-hour continuous infusionMichelle A Rudek, Kenneth S Bauer, Richard M Lush, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 1, 2021
The impact of sarcopenia and acute muscle mass loss on long-term outcomes in critically ill patients with intra-abdominal sepsisMichael C Cox, Matthew Booth, Gabriela Ghita, et al.
The Journal of Urology|February 16, 2005
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastasesWilliam D Figg, Yinong Liu, Philip Arlen, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Surgery|January 4, 2020
Persistently increased cell-free DNA concentrations only modestly contribute to outcome and host response in sepsis survivors with chronic critical illnessRussell B Hawkins, Julie A Stortz, David C Holden, et al.
Critical Care (London, England)|May 9, 2020
Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal studyJulie A Stortz, Michael C Cox, Russell B Hawkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxelMichael C Cox, Jennifer Low, James Lee, et al.
American Journal of Surgery|August 19, 2020
Abdominal sepsis patients have a high incidence of chronic critical illness with dismal long-term outcomesMichael C Cox, Scott C Brakenridge, Julie A Stortz, et al.
JCO Precision Oncology|September 14, 2020
Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring <i>RET</i> Gene AlterationsMichael V Ortiz, Ulrike Gerdemann, Sandya Govinda Raju, et al.
Annals of Surgery|July 30, 2019
Current Epidemiology of Surgical Sepsis: Discordance Between Inpatient Mortality and 1-year OutcomesScott C Brakenridge, Philip A Efron, Michael C Cox, et al.
Journal of the American Geriatrics Society|April 16, 2020
Older Sepsis Survivors Suffer Persistent Disability Burden and Poor Long-Term SurvivalRobert T Mankowski, Stephen D Anton, Gabriela L Ghita, et al.
The Annals of Pharmacotherapy|October 2, 2003
Clinical pharmacology of flavopiridol following a 72-hour continuous infusionMichelle A Rudek, Kenneth S Bauer, Richard M Lush, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 1, 2021
The impact of sarcopenia and acute muscle mass loss on long-term outcomes in critically ill patients with intra-abdominal sepsisMichael C Cox, Matthew Booth, Gabriela Ghita, et al.
The Journal of Urology|February 16, 2005
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastasesWilliam D Figg, Yinong Liu, Philip Arlen, et al.
Pageof 5